The GLP-1 pills work similarly, but these contain a higher dose of medication to compensate for absorption into the digestive ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Long-defined by high prices, shortages and weekly injections, weight loss drugs including Wegovy and Zepbound are expected to ...

Weight loss medication Wegovy is now available in pill form, offering the same active ingredient as weekly injections.

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

In the first human trial of a new therapeutic, a single injection of lepodisiran reduced levels of lipoprotein(a), or Lp(a), to undetectable levels for nearly one year, according to late-breaking ...

Given that HCV is a bloodborne virus, any circumstance that promotes continued drug injection—including failure to prevent or diagnose and adequately treat substance use disorders—can result in ...